CELU (Celularity Inc. Class A Common Stock) Stock Analysis - Insider Trades

Celularity Inc. Class A Common Stock (CELU) is a publicly traded Healthcare sector company. As of May 21, 2026, CELU trades at $0.83 with a market cap of $23.11M and a P/E ratio of -0.31. CELU moved +4.21% today. Year to date, CELU is -34.51%; over the trailing twelve months it is -64.58%. Its 52-week range spans $0.71 to $5.22. Rallies surfaces CELU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CELU stock inside the company?

Rallies tracks CELU insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

CELU Key Metrics

Key financial metrics for CELU
MetricValue
Price$0.83
Market Cap$23.11M
P/E Ratio-0.31
EPS$-2.64
Dividend Yield0.00%
52-Week High$5.22
52-Week Low$0.71
Volume0
Avg Volume0
Revenue (TTM)$54.22M
Net Income$-57.89M
Gross Margin72.36%

Latest CELU News

CELU Analyst Consensus

CELU analyst coverage data. Average price target: $0.00.

Common questions about CELU

Who is trading CELU stock inside the company?
Rallies tracks CELU insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for CELU?
Yes. Rallies tracks CELU insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CELU research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CELU. It does not provide personalized investment advice.
CELU

CELU